CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189760 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Bruno Lorusso und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy. Hauptthemen laut MEDLINE: Dipeptidyl Peptidase 4, Hemangioma, Cell Proliferation, Vildagliptin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Parma.
Abstract (Originalsprache)
Infantile hemangiomas (IHs) are benign vascular neoplasms of childhood (prevalence 5–10%) due to the abnormal proliferation of endothelial cells. IHs are characterized by a peculiar natural life cycle enclosing three phases: proliferative (≤12 months), involuting (≥13 months), and involuted (up to 4–7 years). The mechanisms underlying this neoplastic disease still remain uncovered. Twenty-seven IH tissue specimens (15 proliferative and 12 involuting) were subjected to hematoxylin and eosin staining and a panel of diagnostic markers by immunohistochemistry. WT1, nestin, CD133, and CD26 were also analyzed. Moreover, CD31pos/CD26pos proliferative hemangioma–derived endothelial cells (Hem-ECs) were freshly isolated, exposed to vildagliptin (a DPP-IV/CD26 inhibitor), and tested for cell survival and proliferation by MTT assay, FACS analysis, and Western blot assay. All IHs displayed positive CD31, GLUT1, WT1, and nestin immunostaining but were negative for D2-40. Increased endothelial cell proliferation in IH samples was documented by ki67 labeling. All endothelia of proliferative IHs were positive for CD26 (100%), while only 10 expressed CD133 (66.6%). Surprisingly, seven involuting IH samples (58.3%) exhibited coexisting proliferative and involuting aspects in the same hemangiomatous lesion. Importantly, proliferative areas were characterized by CD26 immunolabeling, at variance from involuting sites that were always CD26 negative. Finally, in vitro DPP-IV pharmacological inhibition by vildagliptin significantly reduced Hem-ECs proliferation through the modulation of ki67 and induced cell cycle arrest associated with the upregulation of p21 protein expression. Taken together, our findings suggest that CD26 might represent a reliable biomarker to detect proliferative sites and unveil non-regressive IHs after a 12-month life cycle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
- Department of Medical Oncology, Metaxa Cancer Hospital of Piraeus, 185 37 Piraeus, Greece.
- Translational Hematology and Chemogenomics (THEC), University of Parma, 43126 Parma, Italy.
- Hematology and BMT Unit, University Hospital of Parma, 43126 Parma, Italy.
- Center of Dental Medicine, University of Parma, 43126 Parma, Italy.
- Pathology Section, University Hospital of Parma, 43126 Parma, Italy.
ORCID-Profile: Bruno Lorusso, Antonella Nogara, Rodanthi Fioretzaki, Roberta Bove, Andrea Gherli, Anna Montanaro, Gregorio Monica, Enrico Maria Silini, Federico Quaini, Costanza Anna Maria Lagrasta
Förderung
- University of Parma
Zitieren
APA
Lorusso, B., Nogara, A., Fioretzaki, R., Corradini, E., Bove, R., Roti, G., Gherli, A., Montanaro, A., Monica, G., Cavazzini, F., Bonomini, S., Graiani, G., Silini, E. M., Gnetti, L., Pilato, F. P., Cerasoli, G., Quaini, F., & Lagrasta, C. A. M. (2024). CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189760
Vancouver
Lorusso B, Nogara A, Fioretzaki R, Corradini E, Bove R, Roti G, et al. CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189760
BibTeX
@article{Lorusso2024,
author = {Lorusso, Bruno and Nogara, Antonella and Fioretzaki, Rodanthi and Corradini, Emilia and Bove, Roberta and Roti, Giovanni and Gherli, Andrea and Montanaro, Anna and Monica, Gregorio and Cavazzini, Filippo and Bonomini, Sabrina and Graiani, Gallia and Silini, Enrico Maria and Gnetti, Letizia and Pilato, Francesco Paolo and Cerasoli, Giuseppe and Quaini, Federico and Lagrasta, Costanza Anna Maria},
title = {CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189760}
}
EUVIMED